Meghan Fitzgerald

Meghan Fitzgerald

Directeur/Membre du Conseil chez ROIVANT SCIENCES LTD.

Fortune : 5 M $ au 30/06/2026

55 ans
Health Technology
Finance
Consumer Services

Profil

Meghan M.
Fitzgerald
is the founder of K2 HealthVentures Group LLC, founded in 2018.
Dr. Fitzgerald is also the founder of K2 HealthVentures LLC.
Current jobs include Independent Director at Tenet Healthcare Corp.
since 2018, Independent Director at Roivant Sciences Ltd. since 2023, Director at Seniorlink, Inc., Director at Quanta Dialysis Technologies Ltd. since 2022, Senior Advisor at Wellspring Capital Management LLC, Assistant Professor-Health Policy at The Trustees of Columbia University in The City of New York since 2014, Member at Harvard Kennedy School of Government, and Advisor at Thimble Point Acquisition Corp.
II.
Former jobs include Chief Executive Officer & Managing Partner at LetterOne Holdings SA, Senior Director-Strategic Planning-Human Health at Pfizer Inc. from 2001 to 2006, Independent Director at Concert Pharmaceuticals, Inc. from 2016 to 2018, Director at Gelesis, Inc., Director at Follica, Inc., Independent Non-Executive Director at Arix Bioscience Plc from 2017 to 2019, Director at Destination Pet LLC, Independent Director at Thimble Point Acquisition Corp.
in 2021, President-Specialty Solutions at Cardinal Health, Inc. from 2015 to 2016, Principal at Merck & Co., Inc., Chief Business Officer & Vice President at Vion Pharmaceuticals, Inc., Senior VP-New Markets International Division at Medco Health Solutions, Inc. from 2008 to 2010, Principal at Pfizer Global Pharmaceuticals, Inc., Principal at Sanofi-Synthelabo, Inc., President at Cardinal Health 122 LLC, and Managing Partner at Letterone Investment Holdings SARL from 2016 to 2019.
Education includes graduate studies at The Trustees of Columbia University in The City of New York, undergraduate studies at Fairfield University, and a doctorate from New York Medical College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
27/05/2026 17 087 ( 0,02 % ) 3 M $ 30/06/2026
30/06/2026 42 963 ( 0,01 % ) 2 M $ 30/06/2026

Postes actifs de Meghan Fitzgerald

SociétésPosteDébut
TENET HEALTHCARE CORPORATION Directeur/Membre du Conseil 29/05/2018
ROIVANT SCIENCES LTD. Directeur/Membre du Conseil 13/03/2023
Consultant / Advisor -
Directeur/Membre du Conseil 10/01/2022
Corporate Officer/Principal -
Corporate Officer/Principal 01/09/2014
Corporate Officer/Principal -
Directeur/Membre du Conseil -

Anciens postes connus de Meghan Fitzgerald

SociétésPosteFin
THIE POIN Directeur/Membre du Conseil 01/12/2021
░░░░░░░░░░░ ░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Meghan Fitzgerald

Formation de Meghan Fitzgerald

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

69

Relations au 1er degré

28

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées28

Distribution Services

Health Technology

Health Technology

Health Services

Health Technology

Finance

Health Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Sanofi-Synthelabo, Inc.

Health Technology

Consumer Services

Technology Services

Technology Services

Health Technology

Consumer Services

Finance

Finance

Finance

Process Industries

Finance

K2 HealthVentures LLC

Finance

Finance

  1. Bourse
  2. Insiders
  3. Meghan Fitzgerald
🔇